Leptin Effect on Acetylation and Phosphorylation of Pgc1α in Muscle Cells Associated With Ampk and Akt Activation in High-Glucose Medium

Journal of Cellular Physiology

Volumn 231, Issue 3, 2016, Pages 641-649

  García Carrizo, Francisco ^a   Nozhenko, Yuriy ^a   Palou, Andreu ^a   Rodríguez, Ana M ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN; CYTOCHROME C OXIDASE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEPTIN; MITOFUSIN 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN KINASE B; PYRUVATE DEHYDROGENASE KINASE 4; SIRTUIN 1; PPARGC1A PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CATALYSIS; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FATTY ACID OXIDATION; IN VITRO STUDY; MOUSE; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; UPREGULATION; ACETYLATION; ANIMAL; CELL LINE; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; SKELETAL MUSCLE;

ACETYLATION; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; ENZYME ACTIVATION; GLUCOSE; LEPTIN; MICE; MUSCLE FIBERS, SKELETAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTION FACTORS;

EID: 84949008085     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25109     Document Type: Article

References (40)

1. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS. 1996. Role of leptin in the neuroendocrine response to fasting. Nature 382:250-252.
2. Akasaka Y, Tsunoda M, Ide T, Murakami K. 2009. Chronic leptin treatment stimulates lipid oxidation in immortalized and primary mouse skeletal muscle cells. Biochim Biophys Acta 1791:103-109.
3. Akasaka Y, Tsunoda M, Ogata T, Ide T, Murakami K. 2010. Direct evidence for leptin-induced lipid oxidation independent of long-form leptin receptor. Biochim Biophys Acta 1801:1115-1122.
4. Andersson B, Wallin G, Hedner T, Ahlberg AC, Andersson OK. 1988. Acute effects of short-term fasting on blood pressure, circulating noradrenaline and efferent sympathetic nerve activity. Acta Med Scand 223:485-490.
5. Anubhuti Arora. 2008. Leptin and its metabolic interactions: An update. Diabetes Obes Metab 10:973-993.
6. Boutant M, Cantó C. 2014. SIRT1 metabolic actions: Integrating recent advances from mouse models. Mol Metab 3:5-18.
7. Cantó C, Auwerx J. 2010. AMP-activated protein kinase and its downstream transcriptional pathways. Cell Mol Life Sci 67:3407-3423.
8. Cantó C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J. 2009. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458:1056-1060.
9. Cantó C, Jiang LQ, Deshmukh AS, Mataki C, Coste A, Lagouge M, Zierath JR, Auwerx J. 2010. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 11:213-219.
10. Chan MC, Arany Z. 2014. The many roles of PGC-1α in muscle-recent developments. Metabolism 63:441-451.
11. Felipe F, Mercader J, Ribot J, Palou A, Bonet ML. 2005. Effects of retinoic acid administration and dietary vitamin A supplementation on leptin expression in mice: Lack of correlation with changes of adipose tissue mass and food intake. Biochim Biophys Acta 1740:258-265.
12. Fernandez-Marcos PJ, Auwerx J. 2011. Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr 93:884S-8890.
13. Frühbeck G. 2006. Intracellular signalling pathways activated by leptin. Biochem J 393:7-20.
14. Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW, Wu Z, Puigserver P. 2007. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J 26:1913-1923.
15. Hardie DG, Ashford ML. 2014. AMPK: Regulating energy balance at the cellular and whole body levels. Physiology (Bethesda) 29:99-107.
16. Hardie DG, Pan DA. 2002. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 30:1064-1070.
17. Higashida K, Kim SH, Jung SR, Asaka M, Holloszy JO, Han DH. 2013. Effects of resveratrol and SIRT1 on PGC-1α activity and mitochondrial biogenesis: A reevaluation. PLoS Biol 11:e1001603.
18. Houten SM, Chegary M, Te Brinke H, Wijnen WJ, Glatz JF, Luiken JJ, Wijburg FA, Wanders RJ. 2009. Pyruvate dehydrogenase kinase 4 expression is synergistically induced by AMP-activated protein kinase and fatty acids. Cell Mol Life Sci 66:1283-1294.
19. Jäger S, Handschin C, St-Pierre J, Spiegelman BM. 2007. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci USA 104:12017-12022.
20. Li L, Pan R, Li R, Niemann B, Aurich AC, Chen Y, Rohrbach S. 2011. Mitochondrial biogenesis and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) deacetylation by physical activity: Intact adipocytokine signaling is required. Diabetes 60:157-167.
21. Li X, Monks B, Ge Q, Birnbaum MJ. 2007. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature 447:1012-1016.
22. Maroni P, Bendinelli P, Piccoletti R. 2003. Early intracellular events induced by in vivo leptin treatment in mouse skeletal muscle. Mol Cell Endocrinol 201:109-121.
23. Maroni P, Bendinelli P, Piccoletti R. 2005. Intracellular signal transduction pathways induced by leptin in C2C12 cells. Cell Biol Int 29:542-550.
24. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Müller C, Carling D, Kahn BB. 2002. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339-343.
25. Molina AJ, Wikstrom JD, Stiles L, Las G, Mohamed H, Elorza A, Walzer G, Twig G, Katz S, Corkey BE, Shirihai OS. 2009. Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. Diabetes 58:2303-2315.
26. 12 muscle and AML12 liver cell lines. Diabetologia 55:215-225.
27. Moreno M, Lombardi A, Silvestri E, Senese R, Cioffi F, Goglia F, Lanni A, de Lange P. 2010. PPARs: Nuclear receptors controlled by, and controlling, nutrient handling through nuclear and cytosolic signaling. PPAR Res 2010.
28. Nozhenko Y, Rodríguez AM, Palou A. 2015. Leptin rapidly induces the expression of metabolic and myokine genes in C2C12 muscle cells to regulate nutrient partition and oxidation. Cell Physiol Biochem 35:92-103.
29. Palou M, Priego T, Sánchez J, Villegas E, Rodríguez AM, Palou A, Picó C. 2008. Sequential changes in the expression of genes involved in lipid metabolism in adipose tissue and liver in response to fasting. Pflugers Arch 456:825-836.
30. Puigserver P, Rhee J, Lin J, Wu Z, Yoon JC, Zhang CY, Krauss S, Mootha VK, Lowell BB, Spiegelman BM. 2001. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell 8:971-982.
31. Soriano FX, Liesa M, Bach D, Chan DC, Palacín M, Zorzano A. 2006. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2. Diabetes 55:1783-1791.
32. Sugden MC, Zariwala MG, Holness MJ. 2009. PPARs and the orchestration of metabolic fuel selection. Pharmacol Res 60:141-150.
33. Sánchez J, Cladera MM, Llopis M, Palou A, Picó C. 2010. The different satiating capacity of CHO and fats can be mediated by different effects on leptin and ghrelin systems. Behav Brain Res 213:183-188.
34. Sánchez J, Nozhenko Y, Palou A, Rodríguez AM. 2013. Free fatty acid effects on myokine production in combination with exercise mimetics. Mol Nutr Food Res 57:1456-1467.
35. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM. 1999. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115-124.
36. Xiong S, Salazar G, San Martin, Patrushev M, Hilenski N, Nazarewicz L, Ma RR, Ushio-Fukai M, Alexander M, 2010. PGC-1 alpha serine 570 phosphorylation and GCN5-mediated acetylation by angiotensin II drive catalase down-regulation and vascular hypertrophy. J Biol Chem 285:2474-2487.
37. Yu H, Lopez E, Young SW, Luo J, Tian H, Cao P. 2006a. Quantitative analysis of free fatty acids in rat plasma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with meso-tetrakis porphyrin as matrix. Anal Biochem 354:182-191.
38. Yu T, Robotham JL, Yoon Y. 2006b. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA 103:2653-2658.
39. Zorzano A, Hernández-Alvarez MI, Palacín M, Mingrone G. 2010. Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes. Biochim Biophys Acta 1797:1028-1033.
40. Zorzano A, Hernández-Alvarez MI, Sebastián D, Muñoz JP. 2015. Mitofusin 2 as a driver that controls energy metabolism and insulin signaling. Antioxid Redox Signal 22:1020-1031.